Bangladesh · Delayed Price · Currency is BDT Renata Company Description
Renata PLC engages in the manufacture, marketing, and distribution of pharmaceuticals, animal health medicines, oncology-based, agro-based, and consumer products in Bangladesh and Portugal.
The company offers generic products, including amantadine, clindamycin, clindamycin, colchicine, dipyridamole, escitalopram, fludrocortisone acetate, hydrocortisone, prednisolone, propylthiouracil, sertraline hydrochloride, terbinafine, and topiramate tablet and capsules.
It also offers specialty products, such as SHK-024, an antidepressant, and SHK 007, to reduce toxicity in pediatrics.
In addition, the company provides animal health products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993.
Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.
| Country | Bangladesh |
| Founded | 1972 |
| Industry | Pharmaceutical Preparations |
| Employees | 8,681 |
| CEO | Syed S. Kabir |
Contact Details
Address: Plot No. 1 Dhaka, 1216 Bangladesh | |
| Phone | 880 2 410 02750 |
| Website | renata-ltd.com |
Stock Details
| Ticker Symbol | RENATA |
| Exchange | Dhaka Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | BDT |
| ISIN Number | BD0457RENAT6 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Syed S. Kabir | Chief Executive Officer |
| Mustafa Aolad | Chief Financial Officer |